858 Therapeutics

858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small-molecule products targeting novel therapeutic targets in oncology, including proteins that modulate RNA and innate immune responses. The company has built a platform to evaluate the impact of RNA-modifying proteins on disease biology and has generated a series of small molecules targeting priority objectives.